Potentiation of retinoic acid-induced differentiation of HL-60 cells by prostaglandin EP2 receptor

Prostaglandins and Other Lipid Mediators

Volumn 56, Issue 2-3, 1998, Pages 145-153

  Ishiguro, Sumie ^a   Takahashi, Noriko ^b   Nemoto, Ken Ichi ^a   Negishi, Manabu ^a   Ichikawa, Atsushi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Differentiation; PGE receptor; Prostaglandin E2; Retinoic acid; Subtype

Indexed keywords

8 BROMO CYCLIC AMP; ADENYLATE CYCLASE; BUTAPROST; CICAPROST; CYCLIC AMP; PROSTAGLANDIN E; PROSTAGLANDIN E RECEPTOR; RECEPTOR SUBTYPE; RETINOIC ACID;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONCENTRATION RESPONSE; DRUG POTENTIATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ALPROSTADIL; CELL DIFFERENTIATION; CYCLIC AMP; DINOPROSTONE; DRUG SYNERGISM; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HL-60 CELLS; HUMANS; PROSTAGLANDINS E, SYNTHETIC; RECEPTORS, LEUKOTRIENE B4; RECEPTORS, PROSTAGLANDIN E; TRETINOIN;

EID: 17744412546     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(98)00051-3     Document Type: Article

References (19)

1. Collins S.J., Gallo R.C., Gallacher R.E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 270:1977;347.
2. Collins S.J., Ruscetti F.W., Gallacher R.E., Gallo R.C. Terminal differentiation of human promyelocytic leukemis cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA. 75:1978;2458.
3. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA. 77:1980;2936.
4. Bunce C.M., French P.J., Durham J., Stockley R.A., Michell R.H., Brown G. Indomethacin potentiates the induction of HL60 differentiation to neutrophils, by retinoic acid and granulocyte colony-stimulating factor, and to monocytes, by vitamin D3. Leukemia. 8:1994;595.
5. Olsson I.L., Breitman T.R., Gallo R.C. Priming of human myeloid leukemic cell lines HL-60 and U-937 with retinoic acid for differentiation effects of cyclic adenosine 3′:5′-monophosphate-inducing agents and a T-lymphocyte-derived differentiation factor. Cancer Res. 42:1982;3928.
6. Negishi M., Sugimoto Y., Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta. 1259:1995;109.
7. Coleman, R.A., Kennedy, I., Humphrey, P.P.A., Bunce, K., Lumley, P. In: Comprehensive Medicinal Chemistry: Prostanoids and their receptors (C. Hansch, P.G. Sammes, J.B. Taylor, and J.C. Emmett, eds.) Pergamon Press, Oxford, 1990, p. 643.
8. Coleman R.A., Smith W.L., Narumiya S. Classification of prostanoid receptors Properties, distribution, and structure of the receptors and their subtypes . Pharmacological Rev. 46:1994;205.
9. Watabe A., Sugimoto Y., Honda A., et al. Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J. Biol. Chem. 268:1993;20175.
10. Katsuyama M., Nishigaki N., Sugimoto Y., et al. The mouse prostaglandin E receptor EP2 subtype Cloning, expression, and northern blot analysis . FEBS Lett. 372:1995;151.
11. Sugimoto Y., Namba T., Honda A., et al. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J. Biol. Chem. 267:1992;6463.
12. Honda A., Sugimoto Y., Namba T., et al. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J. Biol. Chem. 268:1993;7759.
13. Nishigaki N., Negishi M., Honda A., et al. Identification of prostaglandin E receptor 'EP2' cloned from mastocytoma cells as EP4 subtype. FEBS Lett. 364:1995;339.
14. Kotani M., Tanaka I., Ogawa Y., et al. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing multiple second messenger systems and tissue-specific distributions . Mol. Pharmacol. 48:1995;869.
15. Sando T., Usui T., Tanaka I., et al. Molecular cloning and expression of rat prostaglandin E receptor EP2 subtype. Biochem. Biophys. Res. Commun. 200:1994;1329.
16. Bailey T.J., Pepperl D.J., et al. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46:1994;213.
17. Negishi M., Sugimoto Y., Irie A., Narumiya S., Ichikawa A. Two isoforms of prostaglandin E receptor EP3 subtype. J. Biol. Chem. 268:1993;9517.
18. Yokomizo T., Izumi T., Chang K., Takuwa Y., Shimizu T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature. 387:1997;620.
19. Chen Z., Tong J.-H., Dong S., Zhu J., Wang Z.-Y., Chen S.-J. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia. Genes, Chromosomes & Cancer. 15:1996;147.